Inventor · disambiguated record
Nathalie Corvaia
Also filed as: CORVAIA NATHALIE
16 granted patents·9 pending applications·221 citations·filing 2000–2014
93Inventor score
Files withPF MEDICAMENT11GOETSCH LILIANE10MERCK SHARP & DOHME2INST RECH PIERRE FABRE1MERCK SHARP & DOHME CORP ; INST DE RECH PIERRE FABRE1
Top patents by PatentIndex Score
25 records- 0194US8344112B2IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disordersMERCK SHARP & DOHME·Filed 2008·Granted Jan 1, 2013·41 cites·12 claims
- 0293US7241444B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2003·Granted Jul 10, 2007·95 cites·17 claims
- 0389US7914784B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2007·Granted Mar 29, 2011·10 cites·19 claims
- 0488US8071730B2Anti-JAM-A antibodiesGOETSCH LILIANE·Filed 2008·Granted Dec 6, 2011·7 cites·21 claims
- 0587US8361461B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2006·Granted Jan 29, 2013·8 cites·27 claims
- 0687US8124079B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2010·Granted Feb 28, 2012·8 cites·8 claims
- 0786US7854930B2Anti-igf-ir antibodies and uses thereofPF MEDICAMENT·Filed 2005·Granted Dec 21, 2010·7 cites·8 claims
- 0885US8168410B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2011·Granted May 1, 2012·4 cites·14 claims
- 0985US8101180B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2009·Granted Jan 24, 2012·5 cites·12 claims
- 1085US7553485B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofPF MEDICAMENT·Filed 2004·Granted Jun 30, 2009·18 cites·5 claims
- 1184US7524627B2Method of generating and/or increasing an immune response against RSVPF MEDICAMENT·Filed 2007·Granted Apr 28, 2009·3 cites·7 claims
- 1279US7309494B2Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccinePF MEDICAMENT·Filed 2002·Granted Dec 18, 2007·12 cites·5 claims
- 1370US2009181042A1Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccinePF MEDICAMENT·Filed 2009·Application pending·0 cites
- 1469US7033591B1Immunostimulant bacterial membrane fractions in cancer treatmentPF MEDICAMENT·Filed 2000·Granted Apr 25, 2006·3 cites·16 claims
- 1567US2008193445A1Novel anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2007·Application pending·0 cites
- 1658US2015078996A1Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disordersMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1758US2015079080A1Novel anti-igf-ir antibodies and uses thereofMERCK SHARP & DOHME CORP ; INST DE RECH PIERRE FABRE·Filed 2014·Application pending·0 cites
- 1858US2013273031A1Novel anti-igf-ir antibodies and uses thereofINST RECH PIERRE FABRE·Filed 2013·Application pending·0 cites
- 1957US8420085B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2012·Granted Apr 16, 2013·0 cites·8 claims
- 2057US2008063639A1Method for the treatment of psoriasis comprising novel anti-IGF-IR antibodiesPF MEDICAMENT·Filed 2007·Application pending·0 cites
- 2156US8808999B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2012·Granted Aug 19, 2014·0 cites·12 claims
- 2255US8945871B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2013·Granted Feb 3, 2015·0 cites·5 claims
- 2354US2013084243A1Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disordersGOETSCH LILIANE·Filed 2012·Application pending·0 cites
- 2450US2012156191A1Anti-jam-a antibodiesGOETSCH LILIANE·Filed 2011·Application pending·0 cites
- 2539US2013303734A1Novel homogeneous humanized antiproliferation antibodiesGOETSCH LILIANE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathalie Corvaia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →